TARR MARK J (President & CEO) sold 39.3% of their position (173.15K shares) of ENCOMPASS HEALTH CORP on the open market
Open‑market sale worth $21.72M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/11/2026ACC: 0000785161-26-000191
DirectorOfficer· President & CEO
Since Feb 2026
-173.15K
Net shares
Net seller
$21.72M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
173.15K disposed
Non-Derivative Transactions2
Encompass Health Common Stock
Direct
Shares
−171.57K
Price / share
$125.46
Trade value
$21.53M
% of position
38.9%
8/10/2026
440.96K→269.39K
Encompass Health Common Stock
Direct
Shares
−1.58K
Price / share
$126.06
Trade value
$199.05K
% of position
0.6%
8/10/2026
269.39K→267.81K
Total
Net shares
−173.15K
Net value
-$21.72M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Encompass Health Common Stock Direct | 8/10/2026 | S · Sale | −171.57K | $125.46 | $21.53M | 38.9% | 440.96K | 269.39K |
| Encompass Health Common Stock Direct | 8/10/2026 | S · Sale | −1.58K | $126.06 | $199.05K | 0.6% | 269.39K | 267.81K |
| Total | −173.15K | -$21.72M | ||||||
Derivative Transactions0
No derivative transactions reported